Literature DB >> 31010559

Drugs to Control Diabetes During Pregnancy.

Maisa N Feghali1, Jason G Umans2, Patrick M Catalano3.   

Abstract

Diabetes is a common complication of pregnancy associated with both short- and long-term adverse maternal and offspring effects. All types of diabetes in pregnancy are increasing in prevalence. Treatment of diabetes in pregnancy, targeting glycemic control, improves both maternal and offspring outcomes, albeit imperfectly for many women. Pharmacologic treatment recommendations differ between pregestational and gestational diabetes. Improved treatment of diabetes in pregnancy will need to consider maternal disease heterogeneity and comorbidities as well as long-term offspring outcomes. In this review, the authors summarize recent clinical studies to highlight established pharmacologic treatments for diabetes in pregnancy and provide suggestions for further research.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Glucose; Insulin; Pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31010559      PMCID: PMC6481312          DOI: 10.1016/j.clp.2019.02.005

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  93 in total

1.  Insulin lispro and regular insulin in pregnancy.

Authors:  A Bhattacharyya; S Brown; S Hughes; P A Vice
Journal:  QJM       Date:  2001-05

2.  Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.

Authors:  A Santamaria; A Alibrandi; A Di Benedetto; B Pintaudi; F Corrado; F Facchinetti; R D'Anna
Journal:  Am J Obstet Gynecol       Date:  2018-05-30       Impact factor: 8.661

Review 3.  Oral Agents for the Treatment of Gestational Diabetes.

Authors:  Matthew M Finneran; Mark B Landon
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

4.  Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.

Authors:  Angelo Santamaria; Antonino Di Benedetto; Elisabetta Petrella; Basilio Pintaudi; Francesco Corrado; Rosario D'Anna; Isabella Neri; Fabio Facchinetti
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-23

5.  Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice.

Authors:  Marine L Croze; Roxane E Vella; Nicolas J Pillon; Hédi A Soula; Lilas Hadji; Michel Guichardant; Christophe O Soulage
Journal:  J Nutr Biochem       Date:  2012-05-30       Impact factor: 6.048

6.  ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus.

Authors: 
Journal:  Obstet Gynecol       Date:  2018-02       Impact factor: 7.661

7.  A story of two miracles: the impact of the discovery of insulin on pregnancy in women with diabetes mellitus.

Authors:  S G Gabbe
Journal:  Obstet Gynecol       Date:  1992-02       Impact factor: 7.661

8.  Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.

Authors:  Argyro Syngelaki; Kypros H Nicolaides; Jyoti Balani; Steve Hyer; Ranjit Akolekar; Reena Kotecha; Alice Pastides; Hassan Shehata
Journal:  N Engl J Med       Date:  2016-02-04       Impact factor: 91.245

Review 9.  The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug.

Authors:  Francesca Sacco; Alberto Calderone; Luisa Castagnoli; Gianni Cesareni
Journal:  Br J Cancer       Date:  2016-11-22       Impact factor: 7.640

10.  Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis.

Authors:  Nalinee Poolsup; Naeti Suksomboon; Muhammad Amin
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.